The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total debt is โน5.134 Trillion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | โน5.155 T | -4.15% |
2023-12-31 | โน5.378 T | 66.91% |
2022-12-31 | โน3.222 T | 29.99% |
2021-12-31 | โน2.479 T | 2.77% |
2020-12-31 | โน2.412 T | 13.13% |
2019-12-31 | โน2.132 T | -10.12% |
2018-12-31 | โน2.372 T | 5.13% |
2017-12-31 | โน2.256 T | -4.01% |
2016-12-31 | โน2.350 T | 12.56% |
2015-12-31 | โน2.088 T | 7.29% |
2014-12-31 | โน1.946 T | -1.93% |
2013-12-31 | โน1.984 T | 36.65% |
2012-12-31 | โน1.452 T | 28.14% |
2011-12-31 | โน1.133 T | 89.32% |
2010-12-31 | โน598.75 B | 21.73% |
2009-12-31 | โน491.88 B | 0.57% |
2008-12-31 | โน489.10 B | 11.51% |
2007-12-31 | โน438.64 B | 9.9% |
2006-12-31 | โน399.14 B | 124.15% |
2005-12-31 | โน178.06 B | -19.54% |
2004-12-31 | โน221.30 B | 57.81% |
2003-12-31 | โน140.23 B | -7.78% |
2002-12-31 | โน152.06 B | 875.99% |
2001-12-31 | โน15.58 B | 3.45% |
2000-12-31 | โน15.06 B | 7.43% |
1999-12-31 | โน14.02 B | 0.31% |
1998-12-31 | โน13.97 B | 37.31% |
1997-12-31 | โน10.17 B | 59.78% |
1996-12-31 | โน6.37 B |